Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 60/100

Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after market...

Key Takeaway: Penumbra, Inc. has scheduled a conference call for November 2, 2023, to discuss its financial results for the third quarter of 2023. The call is set to take place at 4:30 PM Eastern Time, following the release of a press announcement detailing the financial results. This ongoing communication underscores the company's commitment to transparency and investor relations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of the upcoming earnings call may indicate confidence in financial performance.
  • Penumbra continues to engage with investors through transparent communications.
  • The company supports healthcare providers in over 100 countries, highlighting its global reach.

Full Press Release Details

ALAMEDA, Calif. , Oct. 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after market close on Thursday, November 2, 2023 at 4:30 PM Eastern Time. A press release with third quarter 2023 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at: www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., headquartered in Alameda, California , is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn .
Investor Relations Penumbra, Inc. 510-995-2461 [email protected]
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

When is Penumbra's Q3 2023 earnings call?

The earnings call is on November 2, 2023, at 4:30 PM Eastern Time.

How can I access the earnings call for Penumbra?

Call (888) 330-2443 or visit the 'Events and Presentations' section on their website.

Where can I find Penumbra's financial results?

Third quarter financial results will be released after the market closes on November 2.

What does Penumbra, Inc. focus on?

Penumbra focuses on innovative therapies for challenging medical conditions.

How many countries does Penumbra operate in?

Penumbra supports healthcare providers in over 100 countries worldwide.

Last updated: Oct 5, 2023